Summary
When the tumor-bearing leg of C57BL/6J mice was amputated 16 days after SC inoculation of 106B16 melanoma cells, all the amputated mice died of pulmonary metastases. Transfer of lungs from the amputated to normal syngeneic mice revealed tumor cells in the lungs just after amputation. Repeated weekly injections of BCG and irradiated tumor cells, beginning 24 h after amputation of the tumor-bearing limb, prolonged the survival only of mice presensitized to BCG. Injections of BCG or irradiated melanoma cells alone, of neuraminidase- and mitomycin C-treated tumor cells or of Levamisole had no effect, but injections of ConA-coated tumor cells slightly prolonged the survival of the amputated mice. Both BCG and B16 cells induced humoral and cell-mediated immunity but there was no cross-reactivity between BCG and B16 cells.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Burdette WJ, Gehan EA (1970) In: Planning and analysis of clinical studies. Charles C. Thomas, Springfield, p 72
Burger DR, Hu F, Pasztor LM, Malley A (1973) A model for immunity to melanomas in mice. Proc Soc Exp Biol Med 144:426
Bystryn JC, Bart RS, Livingston P, Kopf AW (1974) Growth and immunogenicity of murine B-16 melanoma. J Invest Dermatol 63:369
Chassoux D, Salomon JC (1975) Therapeutic effect of intratumoral injection of BCG and other substances in rats and mice. Int J Cancer 16:515
Chee DO, Bodurtha AJ (1974) Facilitation and inhibition of B16 melanoma by BCG in vivo and by lymphoid cells from BCG-treated mice in vitro. Int J Cancer 14:137
Falk RE, Zabriskie JB (1971) The capillary technique for measurement of inhibition of leucocyte migration: an assessment of cell-mediated immunity. In: Bloom BR, Glade PR (eds) In vitro methods in cell-mediated immunity. Academic Press, New York, p 301
Fidler IJ (1978) Tumor heterogeneity and the biology of cancer invasion and metastasis. Cancer Res 38:2651
Froese G, Berczi I, Sehon AH (1974) Neuraminidase-induced enhancement of tumor growth in mice. J Natl Cancer Inst 52:1905
Ghose T, Guclu A, Tai J, Norvell ST, MacDonald AS (1976) Active immunoprophylaxis and immunotherapy in two mouse lymphoma models. J Natl Cancer Inst 57:303
Ghose T, Guclu A, Tai J, Mammen M, Norvell ST (1977) Immunoprophylaxis and immunotherapy of EL4 lymphoma. Eur J Cancer 13:925
Hawrylko E, Mackaness GB (1973) Immunopotentiation with BCG. III. Modulation of the response to a tumor-specific antigen. J Natl Cancer Inst 51:1677
Hersh EM, Gutterman JU, Mavligit GM (1977) BCG as adjuvant immunotherapy for neoplasia. Annu Rev Med 28:489
Kreider JW, Bartlett GL, Purnell DM (1976) Inconsistent response of B16 melanoma to BCG immunotherapy. J Natl Cancer Inst 56:803
McCracken JD, Chen T, White J, Samson M, Stephens R, Coltman CA Jr, Saiki J, Lane M, Bonnet J, McGavran M (1982) Combination chemotherapy radiotherapy, and BCG immunotherapy in limited small-cell carcinoma of the lung: a Southwest Oncology Group study. Cancer 49:2252
Martinez C, Miroff G, Bittner J (1956) Effect of size and/or rate of growth of a transplantable mouse adenocarcinoma on lung metastasis production. Cancer Res 16:313
Mastrangelo MJ, Berd D, Bellet RE (1976) Critical review of previously reported clinical trials of cancer immunotherapy with nonspecific immunostimulants. Ann NY Acad Sci 277:94
Mathé G (1969) Approaches to the immunological treatment of cancer in man. Br Med J 4:7
Mathé G (1976) Surviving in company of BCG. Cancer Immunol Immunother 1:3
Proctor JW, Auclair BG, Stokowski L, Mansell PWA, Shibata H (1977) Comparison of effect of BCG, glucan and levamisole on B16 melanoma metastases. Eur J Cancer 13:115
Rios A, Simmons RL (1974) Active specific immunotherapy of minimal residual tumor: excision plus neuraminidase-treated tumor cells. Int J Cancer 13:71
Varella AD, Bandiera DC, DeAmorim AR, Calvis LA, Santos IO, Escaleira N, Gentil F (1981) Treatment of disseminated malignant melanoma with high-dose oral BCG. Cancer 48:1353
Warren L (1959) The thiobarbituric acid assay of sialic acids. J Biol Chem 234:1971
Whitney RB, Levy JG, Smith AG (1974) Influence of tumor size and surgical resection on cell-mediated immunity in mice. J Natl Cancer Inst 53:111
Wood JS Jr, Holyoke ED, Clason WPC, Sommers SC, Warren S (1954) An experimental study of the relationship between tumor size and number of lung metastases. Cancer 7:437
Zbar B (1972) Tumor regression mediated by Mycobacterium bovis (strain BCG). Natl Cancer Inst Monogr 35:341
Author information
Authors and Affiliations
Additional information
Abbreviations used: ConA, concanavalin A; SC, subcutaneous; IP, intraperitoneal; IV, intravenous; ID, intradermal; IT, intratumoral; PBS, phosphate-buffered saline (0.01 M sodium phosphate, pH 7.1); VCN, Vibrio cholerae neuraminidase; HBSS, Hank's balanced salt solution; RPMIM, Roswell Park Memorial Institute medium
Rights and permissions
About this article
Cite this article
Tai, J., Guclu, A., Ghose, T. et al. Inhibition of pulmonary metastases of B16 melanoma with irradiated tumor cells and BCG. Cancer Immunol Immunother 15, 47–53 (1983). https://doi.org/10.1007/BF00199461
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00199461